HMGB1/TLR2,4 axis is associated with therapeutic resistance of human breast cancer

被引：0
|
作者：
Takagi, Kiyoshi [1 ]
Taguchi, Reina [1 ,2 ]
Tanaka, Mio [1 ,3 ]
Sato, Ai [1 ]
Miki, Yasuhiro [4 ]
Miyashita, Minoru [5 ]
Suzuki, Takashi [1 ,2 ,4 ]
机构：
[1] Tohoku Univ, Grad Sch Med, Pathol & Histotech, Sendai, Miyagi, Japan
[2] Tohoku Univ Hosp, Pathol, Sendai, Miyagi, Japan
[3] Tohoku Univ Hosp, Personalized Med Ctr, Sendai, Miyagi, Japan
[4] Tohoku Univ, Grad Sch Med, Anat Pathol, Sendai, Miyagi, Japan
[5] Tohoku Univ, Grad Sch Med, Breast & Endocrine Surg Oncol, Sendai, Miyagi, Japan
来源：
CANCER SCIENCE | 2024年 / 115卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P-3271
引用
收藏
页码：2123 / 2123
页数：1
相关论文
共 50 条
  • [1] HMGB1 interacts with both TLR2 and TLR4
    Park, JS
    Gamboni-Robertson, F
    Abraham, E
    Banerjee, A
    SHOCK, 2005, 23 : 54 - 54
  • [2] HMGB1 signals through toll-like receptor (TLR) 4 and TLR2
    Yu, Man
    Wang, Haichao
    Ding, Aihao
    Golenbock, Douglas T.
    Latz, Eicke
    Czura, Christopher J.
    Fenton, Matthew J.
    Tracey, Kevin J.
    Yang, Huan
    SHOCK, 2006, 26 (02): : 174 - 179
  • [3] Correlation of HMGB1, TLR2 and TLR4 with left ventricular diastolic dysfunction in sepsis patients
    Lv, Xinwei
    Shi, Xiaohui
    Maihemuti, Mutalifu
    Yang, Danping
    Xiao, Dong
    SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 2023, 97 (04)
  • [4] HMGB1 induces chondrocyte hypertrophy and matrix catabolism via TLR2 and TLR4 signaling in chondrocytes
    Bryan, Ru L.
    Terkeltaub, Robert
    ARTHRITIS AND RHEUMATISM, 2008, 58 (09): : S873 - S874
  • [5] Targeting HMGB1: An available Therapeutic Strategy for Breast Cancer Therapy
    Dong, Haonan
    Zhang, Lu
    Liu, Suling
    INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES, 2022, 18 (08): : 3421 - 3434
  • [6] The HMGB1/RAGE axis induces bone pain associated with colonization of 4T1 mouse breast cancer in bone
    Okui, Tatsuo
    Hiasa, Masahiro
    Ryumon, Shoji
    Ono, Kisho
    Kunisada, Yuki
    Ibaragi, Soichiro
    Sasaki, Akira
    Roodman, G. David
    White, Fletcher A.
    Yoneda, Toshiyuki
    JOURNAL OF BONE ONCOLOGY, 2021, 26
  • [7] TLR4 and HMGB1: partners in crime?
    Goligorsky, Michael S.
    KIDNEY INTERNATIONAL, 2011, 80 (05) : 450 - 452
  • [8] HMGB1 Mediates Endogenous TLR2 Activation and Brain Tumor Regression
    Curtin, James F.
    Liu, Naiyou
    Candolfi, Marianela
    Xiong, Weidong
    Assi, Hikmat
    Yagiz, Kader
    Edwards, Matthew R.
    Michelsen, Kathrin S.
    Kroeger, Kurt M.
    Liu, Chunyan
    Muhammad, A. K. M. Ghulam
    Clark, Mary C.
    Arditi, Moshe
    Comin-Anduix, Begonya
    Ribas, Antoni
    Lowenstein, Pedro R.
    Castro, Maria G.
    PLOS MEDICINE, 2009, 6 (01) : 83 - 104
  • [9] HMGB1 as the therapeutic target in gastric cancer
    Takaki, Wataru
    Konishi, Hirotaka
    Arita, Tomohiro
    Kosuga, Toshiyuki
    Shiozaki, Atsushi
    Nakanishi, Masayoshi
    Kubota, Takeshi
    Fujiwara, Hitoshi
    Okamoto, Kazuma
    Otsuji, Eigo
    CANCER SCIENCE, 2021, 112 : 429 - 429
  • [10] Macrophage migration inhibitory factor promotes breast cancer metastasis via activation of HMGB1/TLR4/NF kappa B axis
    Lv, Wei
    Chen, Na
    Lin, Yanliang
    Ma, Hongyan
    Ruan, Yongwei
    Li, Zhiwei
    Li, Xungeng
    Pan, Xiaohua
    Tian, Xingsong
    CANCER LETTERS, 2016, 375 (02) : 245 - 255
12345